Hearing loss has no restorative medical treatments and often involves several different genetic factors, making it difficult to treat unless caused by trauma. As a result, pharmaceutical companies have been reluctant to invest in research, and patients are typically limited to assistive devices such as hearing aids. While the research is still in its early stages, The Jerusalem Post reports that a new study from Tel Aviv University (TAU) offers promising insight into what future treatments for hearing loss could look like.
Researchers from TAU’s Gray Faculty of Medical and Health Sciences have identified a regenerative mechanism in cells that can become replacement sensory hair cells in the inner ear. These hair cells are essential for hearing because they convert sound vibrations into electrical signals that are sent to the brain. Outer hair cells detect and amplify sound vibrations, while inner hair cells transmit those signals to the brain. When these cells are damaged, they typically do not regenerate, resulting in permanent hearing loss—until now.
The team uncovered a rare subset of supporting cells with an unexpected regenerative potential. Rather than responding uniformly, only a distinct group of cells entered a transitional state and began converting into hair cells, which exist naturally as a kind of “reserve population” that everyone has. Some people, however, may naturally have more regenerative potential than others, Prof. Karen Avraham noted.
These cells, termed transdifferentiating Deiters’ cells (tDCs), are capable of making the transition from supporting cells to hair cells – a step that is vital for hair cell regeneration.
Using live tissue imaging and single-cell multi-omics methods that incorporate biological layers to trace the flow of information in a cell, “we focused on supporting cells that are adjacent to the hair cells. Under normal conditions, these cannot regenerate or transform into hair cells,” said Avraham.
Avraham said that any future treatment would likely involve an injection administered by a surgeon. She also noted that this research would not have been possible just five years ago because the necessary technology did not yet exist. However, regulatory approval and cost remain significant hurdles before such a treatment could become widely available.
The research is still in its earliest stages, with only one subpopulation of cells demonstrating regenerative capacity. The next step is to determine how this regenerative ability can be expanded to other cells within the inner ear.
Although much work remains, the findings represent an important first step toward a better understanding of the auditory system and the development of future treatments for hearing loss.